Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2010

01.06.2010 | Preclinical study

A prospective study of variability in mammographic density during the menstrual cycle

verfasst von: Monica Morrow, Robert T. Chatterton Jr., Alfred W. Rademaker, Nanjiang Hou, V. Craig Jordan, R. Edward Hendrick, Seema A. Khan

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Mammographic breast density has been proposed as a surrogate endpoint in breast cancer prevention studies, but little is known about its variability over time, particularly in relation to menstrual cycle phase. The purpose of this study was to assess variation in breast density on digital mammograms using quantitative and qualitative density measures. Menstrual cycle phase was determined by salivary estradiol and progesterone assays. 73 healthy subjects with regular menses had 1–3 mammograms with paired saliva collection during a 12-month period. The mean difference in density as a percentage of the mean density was calculated for follicular–luteal (n = 50), luteal–luteal (n = 26) and follicular–follicular (n = 23) pairs in the same woman using the same breast. Two density measures (measurement of dense area and BIRADS) were used. The mean luteal density exceeded the mean follicular density by 7.1–9.2%, but density differences between luteal pairs and follicular pairs did not exceed 5%. The intraclass correlation for measurement of dense area was greater than 85% in all phases of the menstrual cycle, but was below 50% for BIRADS for luteal–follicular and follicular–follicular pairs. Our study provides estimates of the amount of variation in mammographic density during the menstrual cycle, and that inherent in repeated density measurement in premenopausal women, and suggests that menstrual phase of mammographic evaluation should be controlled for in intervention studies where density is being used as a surrogate measure.
Literatur
1.
Zurück zum Zitat Vacek PM, Geller BM (2004) A prospective study of breast cancer risk using routine mammographic breast density measurements. Cancer Epidemiol Biomarkers Prev 13:715–722PubMed Vacek PM, Geller BM (2004) A prospective study of breast cancer risk using routine mammographic breast density measurements. Cancer Epidemiol Biomarkers Prev 13:715–722PubMed
2.
Zurück zum Zitat Boyd NF, Jensen HM, Cooke G, Han HL, Lockwood GA, Miller AB (2000) Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Reference pathologists of the Canadian national breast screening study. Eur J Cancer Prev 9:15–24CrossRefPubMed Boyd NF, Jensen HM, Cooke G, Han HL, Lockwood GA, Miller AB (2000) Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Reference pathologists of the Canadian national breast screening study. Eur J Cancer Prev 9:15–24CrossRefPubMed
3.
Zurück zum Zitat Byrne C, Schairer C, Wolfe J et al (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87:1622–1629CrossRefPubMed Byrne C, Schairer C, Wolfe J et al (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87:1622–1629CrossRefPubMed
4.
Zurück zum Zitat Ciatto S, Visioli C, Paci E, Zappa M (2004) Breast density as a determinant of interval cancer at mammographic screening. Br J Cancer 90:393–396CrossRefPubMed Ciatto S, Visioli C, Paci E, Zappa M (2004) Breast density as a determinant of interval cancer at mammographic screening. Br J Cancer 90:393–396CrossRefPubMed
5.
Zurück zum Zitat Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V (1996) Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 276:33–38CrossRefPubMed Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V (1996) Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 276:33–38CrossRefPubMed
6.
Zurück zum Zitat Mandelson MT, Oestreicher N, Porter PL et al (2000) Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 92:1081–1087CrossRefPubMed Mandelson MT, Oestreicher N, Porter PL et al (2000) Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 92:1081–1087CrossRefPubMed
7.
Zurück zum Zitat Baines CJ, Vidmar M, McKeown-Eyssen G, Tibshirani R (1997) Impact of menstrual phase on false-negative mammograms in the Canadian national breast screening study. Cancer 80:720–724CrossRefPubMed Baines CJ, Vidmar M, McKeown-Eyssen G, Tibshirani R (1997) Impact of menstrual phase on false-negative mammograms in the Canadian national breast screening study. Cancer 80:720–724CrossRefPubMed
8.
Zurück zum Zitat White E, Velentgas P, Mandelson MT et al (1998) Variation in mammographic breast density by time in menstrual cycle among women aged 40–49 years. J Natl Cancer Inst 90:906–910CrossRefPubMed White E, Velentgas P, Mandelson MT et al (1998) Variation in mammographic breast density by time in menstrual cycle among women aged 40–49 years. J Natl Cancer Inst 90:906–910CrossRefPubMed
9.
Zurück zum Zitat Ursin G, Parisky YR, Pike MC, Spicer DV (2001) Mammographic density changes during the menstrual cycle. Cancer Epidemiol Biomarkers Prev 10:141–142PubMed Ursin G, Parisky YR, Pike MC, Spicer DV (2001) Mammographic density changes during the menstrual cycle. Cancer Epidemiol Biomarkers Prev 10:141–142PubMed
10.
Zurück zum Zitat Warren RM, Young JR, McLean L et al (2003) Radiology review of the UKCCCR Breast Screening Frequency Trial: potential improvements in sensitivity, lead time of radiological signs. Clin Radiol 58:128–132CrossRefPubMed Warren RM, Young JR, McLean L et al (2003) Radiology review of the UKCCCR Breast Screening Frequency Trial: potential improvements in sensitivity, lead time of radiological signs. Clin Radiol 58:128–132CrossRefPubMed
11.
Zurück zum Zitat Rosenberg RD, Hunt WC, Williamson MR et al (1998) Effects of age, breast density, ethnicity, estrogen replacement therapy on screening mammographic sensitivity, cancer stage at diagnosis: review of 183, 134 screening mammograms in Albuquerque, New Mexico. Radiology 209:511–518PubMed Rosenberg RD, Hunt WC, Williamson MR et al (1998) Effects of age, breast density, ethnicity, estrogen replacement therapy on screening mammographic sensitivity, cancer stage at diagnosis: review of 183, 134 screening mammograms in Albuquerque, New Mexico. Radiology 209:511–518PubMed
12.
Zurück zum Zitat Destounis SV, DiNitto P, Logan-Young W, Bonaccio E, Zuley ML, Willison KM (2004) Can computer-aided detection with double reading of screening mammograms help decrease the false-negative rate? Initial experience. Radiology 232:578–584CrossRefPubMed Destounis SV, DiNitto P, Logan-Young W, Bonaccio E, Zuley ML, Willison KM (2004) Can computer-aided detection with double reading of screening mammograms help decrease the false-negative rate? Initial experience. Radiology 232:578–584CrossRefPubMed
13.
Zurück zum Zitat Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1994) The quantitative analysis of mammographic densities. Phys Med Biol 39:1629–1638CrossRefPubMed Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1994) The quantitative analysis of mammographic densities. Phys Med Biol 39:1629–1638CrossRefPubMed
14.
Zurück zum Zitat Jong R, Fishell E, Little L, Lockwood G, Boyd NF (1996) Mammographic signs of potential relevance to breast cancer risk: the agreement of radiologists’ classification. Eur J Cancer Prev 5:281–286CrossRefPubMed Jong R, Fishell E, Little L, Lockwood G, Boyd NF (1996) Mammographic signs of potential relevance to breast cancer risk: the agreement of radiologists’ classification. Eur J Cancer Prev 5:281–286CrossRefPubMed
15.
Zurück zum Zitat Chatterton RT Jr, Mateo ET, Hou N et al (2005) Characteristics of salivary profiles of oestradiol and progesterone in premenopausal women. J Endocrinol 186:77–84CrossRefPubMed Chatterton RT Jr, Mateo ET, Hou N et al (2005) Characteristics of salivary profiles of oestradiol and progesterone in premenopausal women. J Endocrinol 186:77–84CrossRefPubMed
16.
Zurück zum Zitat Lu YC, Chatterton RT Jr, Vogelsong KM, May LK (1997) Direct radioimmunoassay of progesterone in saliva. J Immunoassay 18:149–163CrossRefPubMed Lu YC, Chatterton RT Jr, Vogelsong KM, May LK (1997) Direct radioimmunoassay of progesterone in saliva. J Immunoassay 18:149–163CrossRefPubMed
17.
Zurück zum Zitat Lu Y, Bentley GR, Gann PH, Hodges KR, Chatterton RT (1999) Salivary estradiol and progesterone levels in conception and nonconception cycles in women: evaluation of a new assay for salivary estradiol. Fertil Steril 71:863–868CrossRefPubMed Lu Y, Bentley GR, Gann PH, Hodges KR, Chatterton RT (1999) Salivary estradiol and progesterone levels in conception and nonconception cycles in women: evaluation of a new assay for salivary estradiol. Fertil Steril 71:863–868CrossRefPubMed
18.
Zurück zum Zitat Kivlighan KT, Granger DA, Schwartz EB (2005) Blood contamination and the measurement of salivary progesterone and estradiol. Horm Behav 47:367–370CrossRefPubMed Kivlighan KT, Granger DA, Schwartz EB (2005) Blood contamination and the measurement of salivary progesterone and estradiol. Horm Behav 47:367–370CrossRefPubMed
19.
Zurück zum Zitat Vitzthum VJ, Bentley GR, Spielvogel H et al (2002) Salivary progesterone levels and rate of ovulation are significantly lower in poorer than in better-off urban-dwelling Bolivian women. Hum Reprod 17:1906–1913CrossRefPubMed Vitzthum VJ, Bentley GR, Spielvogel H et al (2002) Salivary progesterone levels and rate of ovulation are significantly lower in poorer than in better-off urban-dwelling Bolivian women. Hum Reprod 17:1906–1913CrossRefPubMed
20.
Zurück zum Zitat Lipson SF, Ellison PT (1996) Comparison of salivary steroid profiles in naturally occurring conception and non-conception cycles. Hum Reprod 11:2090–2096PubMed Lipson SF, Ellison PT (1996) Comparison of salivary steroid profiles in naturally occurring conception and non-conception cycles. Hum Reprod 11:2090–2096PubMed
21.
Zurück zum Zitat Byng JW, Yaffe MJ, Jong RA et al (1998) Analysis of mammographic density and breast cancer risk from digitized mammograms. Radiographics 18:1587–1598PubMed Byng JW, Yaffe MJ, Jong RA et al (1998) Analysis of mammographic density and breast cancer risk from digitized mammograms. Radiographics 18:1587–1598PubMed
23.
Zurück zum Zitat Lin LI (1989) A concordance correlation coefficient to evaluate reproducibility. Biometrics 45:255–268CrossRefPubMed Lin LI (1989) A concordance correlation coefficient to evaluate reproducibility. Biometrics 45:255–268CrossRefPubMed
24.
Zurück zum Zitat Johns PC, Yaffe MJ (1987) X-ray characterisation of normal and neoplastic breast tissues. Phys Med Biol 32:675–695CrossRefPubMed Johns PC, Yaffe MJ (1987) X-ray characterisation of normal and neoplastic breast tissues. Phys Med Biol 32:675–695CrossRefPubMed
25.
Zurück zum Zitat Li T, Sun L, Miller N et al (2005) The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 14:343–349CrossRefPubMed Li T, Sun L, Miller N et al (2005) The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 14:343–349CrossRefPubMed
26.
Zurück zum Zitat Guo YP, Martin LJ, Hanna W et al (2001) Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 10:243–248PubMed Guo YP, Martin LJ, Hanna W et al (2001) Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 10:243–248PubMed
27.
Zurück zum Zitat Vogel PM, Georgiade NG, Fetter BF, Vogel FS, McCarty KS Jr (1981) The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol 104:23–34PubMed Vogel PM, Georgiade NG, Fetter BF, Vogel FS, McCarty KS Jr (1981) The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol 104:23–34PubMed
28.
Zurück zum Zitat Longacre TA, Bartow SA (1986) A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 10:382–393CrossRefPubMed Longacre TA, Bartow SA (1986) A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 10:382–393CrossRefPubMed
29.
Zurück zum Zitat Boyd NF, Stone J, Martin LJ et al (2002) The association of breast mitogens with mammographic densities. Br J Cancer 87:876–882CrossRefPubMed Boyd NF, Stone J, Martin LJ et al (2002) The association of breast mitogens with mammographic densities. Br J Cancer 87:876–882CrossRefPubMed
30.
Zurück zum Zitat Noh JJ, Maskarinec G, Pagano I, Cheung LW, Stanczyk FZ (2006) Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women. Breast 15:20–28CrossRefPubMed Noh JJ, Maskarinec G, Pagano I, Cheung LW, Stanczyk FZ (2006) Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women. Breast 15:20–28CrossRefPubMed
31.
Zurück zum Zitat Carney PA, Miglioretti DL, Yankaskas BC et al (2003) Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138:168–175PubMed Carney PA, Miglioretti DL, Yankaskas BC et al (2003) Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138:168–175PubMed
32.
Zurück zum Zitat Boyd NF, Dite GS, Stone J et al (2002) Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 347:886–894CrossRefPubMed Boyd NF, Dite GS, Stone J et al (2002) Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 347:886–894CrossRefPubMed
33.
Zurück zum Zitat Ursin G, Ma H, Wu AH et al (2003) Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 12:332–338PubMed Ursin G, Ma H, Wu AH et al (2003) Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 12:332–338PubMed
34.
Zurück zum Zitat Atkinson C, Warren R, Bingham SA, Day NE (1999) Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen. Cancer Epidemiol Biomarkers Prev 8:863–866PubMed Atkinson C, Warren R, Bingham SA, Day NE (1999) Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen. Cancer Epidemiol Biomarkers Prev 8:863–866PubMed
35.
Zurück zum Zitat Chow CK, Venzon D, Jones EC, Premkumar A, O’Shaughnessy J, Zujewski J (2000) Effect of tamoxifen on mammographic density. Cancer Epidemiol Biomarkers Prev 9:917–921PubMed Chow CK, Venzon D, Jones EC, Premkumar A, O’Shaughnessy J, Zujewski J (2000) Effect of tamoxifen on mammographic density. Cancer Epidemiol Biomarkers Prev 9:917–921PubMed
36.
Zurück zum Zitat Brisson J, Brisson B, Cote G, Maunsell E, Berube S, Robert J (2000) Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 9:911–915PubMed Brisson J, Brisson B, Cote G, Maunsell E, Berube S, Robert J (2000) Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 9:911–915PubMed
37.
Zurück zum Zitat Fisher B, Costantino JP, Wickerham DL et al (2005) Tamoxifen for the prevention of breast cancer: current status of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 97:1652–1662PubMedCrossRef Fisher B, Costantino JP, Wickerham DL et al (2005) Tamoxifen for the prevention of breast cancer: current status of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 97:1652–1662PubMedCrossRef
38.
Zurück zum Zitat Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW (2004) Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 96:621–628PubMed Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW (2004) Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 96:621–628PubMed
39.
Zurück zum Zitat Cuzick J, Warwick J, Pinney L et al (2009) Change in breast density as a biomarker of breast cancer risk reduction; results from IBIS-1. Cancer Res 69(Supplement 2):61 Cuzick J, Warwick J, Pinney L et al (2009) Change in breast density as a biomarker of breast cancer risk reduction; results from IBIS-1. Cancer Res 69(Supplement 2):61
Metadaten
Titel
A prospective study of variability in mammographic density during the menstrual cycle
verfasst von
Monica Morrow
Robert T. Chatterton Jr.
Alfred W. Rademaker
Nanjiang Hou
V. Craig Jordan
R. Edward Hendrick
Seema A. Khan
Publikationsdatum
01.06.2010
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2010
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-009-0496-9

Weitere Artikel der Ausgabe 3/2010

Breast Cancer Research and Treatment 3/2010 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.